| - GRCh37:
- Chr16:50744866
- GRCh38:
- Chr16:50710955
| NOD2 | | Regional enteritis, Blau syndrome, Inflammatory bowel disease 1, Yao syndrome, Blau syndrome, Psoriatic arthritis, susceptibility to
| Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50744940
- GRCh38:
- Chr16:50711029
| NOD2 | R346H, R373H | Regional enteritis, Blau syndrome, Inflammatory bowel disease 1, Yao syndrome, Blau syndrome | Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50745746
- GRCh38:
- Chr16:50711835
| NOD2 | R615G, R642G | Regional enteritis, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1, Blau syndrome | Uncertain significance (Jan 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50746019
- GRCh38:
- Chr16:50712108
| NOD2 | V706M, V733M | Regional enteritis, Blau syndrome, Blau syndrome, Psoriatic arthritis, susceptibility to, Yao syndrome, Inflammatory bowel disease 1, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1
| Uncertain significance (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50744990
- GRCh38:
- Chr16:50711079
| NOD2 | D363N, D390N | Regional enteritis, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1, Blau syndrome | Uncertain significance (Oct 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50733636
- GRCh38:
- Chr16:50699725
| NOD2 | I104T, I77T | not provided, Blau syndrome, Regional enteritis, Inflammatory bowel disease 1, Blau syndrome, Yao syndrome
| Uncertain significance (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50744652
- GRCh38:
- Chr16:50710741
| NOD2 | G250D, G277D | Yao syndrome | Uncertain significance (Jan 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:50745609
- GRCh38:
- Chr16:50711698
| NOD2 | T569M, T596M | Regional enteritis, Blau syndrome, Blau syndrome, Inflammatory bowel disease 1, Yao syndrome, Blau syndrome
| Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50745873
- GRCh38:
- Chr16:50711962
| NOD2 | R657Q, R684Q | Autoinflammatory syndrome, Yao syndrome, Blau syndrome, Psoriatic arthritis, susceptibility to, Inflammatory bowel disease 1, Blau syndrome, Regional enteritis, Yao syndrome, Blau syndrome, Inflammatory bowel disease 1 | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50746198
- GRCh38:
- Chr16:50712287
| NOD2 | | Blau syndrome, Regional enteritis, Inflammatory bowel disease 1, Blau syndrome, Yao syndrome | Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50745432
- GRCh38:
- Chr16:50711521
| NOD2 | P537H, P510H | Inflammatory bowel disease 1, Yao syndrome, Blau syndrome
| Uncertain significance (Dec 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:50733428
- GRCh38:
- Chr16:50699517
| NOD2 | Q35*, Q8* | Yao syndrome, Blau syndrome, Regional enteritis, Blau syndrome | Uncertain significance (Apr 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50753917
- GRCh38:
- Chr16:50720006
| NOD2 | | Inflammatory bowel disease 1, Regional enteritis, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1, Psoriatic arthritis, susceptibility to, Blau syndrome, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1, Blau syndrome ...see more | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50746086
- GRCh38:
- Chr16:50712175
| NOD2 | A755V, A728V | Autoinflammatory syndrome, Inflammatory bowel disease 1, Yao syndrome, Inflammatory bowel disease 1, Psoriatic arthritis, susceptibility to, Blau syndrome, Regional enteritis, Blau syndrome, not provided, Blau syndrome | Conflicting interpretations of pathogenicity (Jun 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50745996
- GRCh38:
- Chr16:50712085
| NOD2 | A725G, A698G | Inflammatory bowel disease 1, Regional enteritis, Blau syndrome, Autoinflammatory syndrome, not provided, Blau syndrome, Yao syndrome, Inflammatory bowel disease 1, Blau syndrome
| Benign/Likely benign (Dec 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50744753
- GRCh38:
- Chr16:50710842
| NOD2 | R311W, R284W | Inflammatory bowel disease 1, Blau syndrome, Regional enteritis, Blau syndrome, not provided, Yao syndrome, Blau syndrome, Inflammatory bowel disease 1 | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50757276
- GRCh38:
- Chr16:50723365
| NOD2 | V955I, V928I | Inflammatory bowel disease 1, Yao syndrome, Blau syndrome, Psoriatic arthritis, susceptibility to, Inflammatory bowel disease 1, Blau syndrome, Regional enteritis, Autoinflammatory syndrome, not provided, Blau syndrome | Benign/Likely benign (Nov 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50746002
- GRCh38:
- Chr16:50712091
| NOD2 | P727L, P700L | Blau syndrome, Regional enteritis, Yao syndrome, Blau syndrome, Inflammatory bowel disease 1 | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50745063
- GRCh38:
- Chr16:50711152
| NOD2 | N414S, N387S | Blau syndrome, Regional enteritis, Yao syndrome, Blau syndrome, Inflammatory bowel disease 1 | Uncertain significance (Apr 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:50745656
- GRCh38:
- Chr16:50711745
| NOD2 | A612T, A585T | Blau syndrome, Regional enteritis, Yao syndrome, Psoriatic arthritis, susceptibility to, Blau syndrome, Inflammatory bowel disease 1, Inflammatory bowel disease 1, not provided, Blau syndrome, Yao syndrome, Blau syndromeInflammatory bowel disease 1, ...see more | Conflicting interpretations of pathogenicity (Sep 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50756774
- GRCh38:
- Chr16:50722863
| NOD2 | | Yao syndrome, Autoinflammatory syndrome, Blau syndrome, Inflammatory bowel disease 1, not provided | Conflicting interpretations of pathogenicity (Nov 21, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50745926
- GRCh38:
- Chr16:50712015
| NOD2 | R702W, R675W | Yao syndrome, Blau syndrome, Regional enteritis, Autoinflammatory syndrome, Inflammatory bowel disease 1, not provided, not specified, Blau syndrome | Conflicting interpretations of pathogenicity; association (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50756540
- GRCh38:
- Chr16:50722629
| NOD2 | G908R, G881R | Blau syndrome, Regional enteritis, Autoinflammatory syndrome, Yao syndrome, Psoriatic arthritis, susceptibility to, Blau syndrome, Inflammatory bowel disease 1, Inflammatory bowel disease 1, not provided, not specified, Blau syndrome ...see more | Conflicting interpretations of pathogenicity; association (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:50763778-50763779
- GRCh38:
- Chr16:50729867-50729868
| CYLD-AS1, NOD2 | L980fs, L1007fs | Blau syndrome, Regional enteritis, Autoinflammatory syndrome, Crohn disease, not provided, Blau syndrome, Yao syndrome, Blau syndrome, Inflammatory bowel disease 1
| Conflicting interpretations of pathogenicity; association (Nov 3, 2022) | criteria provided, conflicting interpretations |